norfloxacin has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, A | 1 |
| Piccolo, V | 1 |
| Russo, T | 1 |
| Cozzolino, D | 1 |
| Mascolo, M | 1 |
| Chessa, MA | 1 |
1 other study available for norfloxacin and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: the enigma of the Rowell syndrome.
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Erythema Multiforme; Female; H | 2014 |